Toll-free:1-888-852-8623

All categories

  • All categories
  • Flow Cytometry Antibodies
  • ELISA Kits
  • MACS Cell Isolation
  • Antibodies and Reagents
  • Cell Health Detection
  • Metabolism Assays
  • Immunoassays
  • Cell Identification
  • Proteins and Peptides
  • Cell Culture
Please enter the item number/product keyword!
Keyword cannot be empty !
INSERT SYMBOLS:
  • α
  • β
  • γ
  • δ
  • ε
  • ζ
  • η
  • θ
  • κ
  • μ
  • ω
  • σ
  • τ
  • λ
  • ⅩⅢ
  • ⅩⅢ
  • ⅩⅣ
  • ⅩⅤ
  • ⅩⅦ
  • ⅩⅧ
  • UP ↑

Cancer Research Antibodies

Source: Elabscience®Published: Feb 05,2024

At present, more than 30 antibodies or antibody derivatives have been approved for cancer treatment by FDA, and hundreds of antibodies are in the process of clinical trials. Antibodies have become a new choice for cancer treatment. Anti-cancer antibodies can target a wide range of antigens, including soluble proteins, cancer cell surface antigens and effector cell receptors.

The versatility of antibodies enables antibodies to take a variety of mechanisms, including direct blocking of growth factors, regulation of the immune system, and interruption or induction of signal transduction pathways. In addition, antibodies are increasingly used as carriers to improve the specificity of specific chemotherapeutic drugs.


Advantages of Elabscience ® Cancer Antibodies

High antigen purity:The purity of each recombinant protein used as an immunogen is ≥90%, part of which are ≥ 95%.

High antibody specificity:Antibodies with high affinity antigen specificity were obtained by antigen affinity purification.

Full and accurate data of cancer antibodies:WB experimental operation guidelines include all the experimental conditions in the WB experimental process. The products have been strictly verified and the datas are accurate and reliable.

Comprehensive and accurate experimental data:Multi species and applications quality detection to ensure that each antibody is a high-quality product that has been strictly screened.


Cancer Research Antibodies

Lung Cancer
Colorectal Cancer
Gastric Cancer
Reproductive System Cancer
Breast Cancer
Liver Cancer
Esophageal Cancer
Pancreatic Cancer
Thyroid Cancer
Lymph Cancer
Leukemia
Cardio-cerebrovascular Disease


Popular Antibodies in cancer research

PTEN-- Tumor suppressor gene

PTEN is a widespread and closely related tumor suppressor gene, which has abnormal expression in glioblastoma, breast cancer, lung cancer, bladder cancer, thyroid cancer, head and neck squamous cell carcinoma, melanoma, lymphoma and other tumors.

POSTN—Periostin

POSTN is an extracellular matrix periosteal protein, which can support the growth of transferase in the formed microenvironment by enhancing Wnt signaling in tumor cells. In adults, it is expressed in specific organs such as breast, bone, skin and intestine.

AFP-- Alpha fetoprotein

Alpha fetoprotein is closely related to the occurrence and development of liver cancer and many kinds of tumors. It shows high concentration in many kinds of tumors and can be used as a positive detection index for many kinds of tumors.

EGFR-- Epidermal growth factor receptor

There are high or abnormal expression of EGFR in many solid tumors. EGFR is related to tumor cell proliferation, angiogenesis, tumor invasion, metastasis and inhibition of apoptosis.

CK-18-- Cytokeratin 18

CK18 is a normal cytoskeleton component of hepatocytes and a standard of tumor markers. CK18 levels were increased in patients with benign liver disease, especially those with significant cytolysis.

IL-6R-- Interleukin-6 receptor

IL-6R can specifically combine with IL-6 to block the related diseases caused by IL-6 and reduce the severity of asthma, multiple sclerosis, chronic rheumatoid arthritis and other diseases.